K Number
K022047
Device Name
PHLEBOTEST 2000
Date Cleared
2002-11-04

(133 days)

Product Code
Regulation Number
870.2780
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Phlebotest 2000 is a system for peripheral vascular diagnostic investigations. Outflow phethysmography (OP) Passive Drain and Refill (PDR) Exercise Venous Plethysmography (EVP) Triple Test (TTT) Combination of OP, PDR, and EVP Either Strain Gauges or Air Pressure Cuffs Prescription device by a physician
Device Description
The PHLEBOTEST 2000 is a system designed for peripheral vascular diagnostic investigations. The center of the system is a specially developed patient chair, which can be positioned according to the investigation performed. The patient can be in a sitting or laying position, with legs positioned in different angels using the movable heel and foot support. Patient elevation between laying and sitting positions can be carried out in various speeds according to investigational requirements. All movements are carried out with low-voltage electrical motors and are directed by a remote hand controller. A pneumatic system consisting of a compressor, pressure tank and valve system is integrated in the system. Different sensors can be attached to the patients for measuring the various examination possibilities. The sensors and pneumatic system are fully integrated and controlled by hardware and software in connection with a PC Windows-based computer. A number of special developed software programs for various diagnostic tests support the system.
More Information

Not Found

No
The description focuses on mechanical and pneumatic systems, sensors, and standard software for diagnostic tests, with no mention of AI or ML capabilities.

No.
The device is described as a system for "peripheral vascular diagnostic investigations" and its functions (Outflow plethysmography, Passive Drain and Refill, Exercise Venous Plethysmography, Triple Test) are all diagnostic in nature, not therapeutic.

Yes

The "Intended Use / Indications for Use" section explicitly states "Phlebotest 2000 is a system for peripheral vascular diagnostic investigations." and lists various diagnostic procedures. The "Device Description" also refers to it as a system designed for "peripheral vascular diagnostic investigations."

No

The device description explicitly mentions hardware components such as a patient chair, electrical motors, a pneumatic system (compressor, pressure tank, valve system), and sensors, in addition to the software.

Based on the provided information, the Phlebotest 2000 is not an In Vitro Diagnostic (IVD) device.

Here's why:

  • IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for diagnostic purposes.
  • Phlebotest 2000 Function: The Phlebotest 2000 is described as a system for peripheral vascular diagnostic investigations using techniques like plethysmography (measuring volume changes in a body part). It uses sensors attached to the patient and a pneumatic system.
  • Lack of Specimen Handling: The description does not mention the collection, preparation, or analysis of any specimens taken from the patient's body. The measurements are taken directly on the patient's body.

Therefore, the Phlebotest 2000 falls under the category of a diagnostic device that interacts directly with the patient's body, rather than analyzing specimens taken from the body.

N/A

Intended Use / Indications for Use

  • Phlebotest 2000 is a system for peripheral vascular diagnostic investigations.
    • Outflow phethysmography (OP)
    • Passive Drain and Refill (PDR)
    • Exercise Venous Plethysmography (EVP)
    • Triple Test (TTT) Combination of OP, PDR, and EVP
    • Either Strain Gauges or Air Pressure Cuffs
    • Prescription device by a physician

Product codes (comma separated list FDA assigned to the subject device)

JOM

Device Description

The PHLEBOTEST 2000 is a system designed for peripheral vascular diagnostic investigations.

The center of the system is a specially developed patient chair, which can be positioned according to the investigation performed. The patient can be in a sitting or laying position, with legs positioned in different angels using the movable heel and foot support. Patient elevation between laying and sitting positions can be carried out in various speeds according to investigational requirements.

All movements are carried out with low-voltage electrical motors and are directed by a remote hand controller. A pneumatic system consisting of a compressor, pressure tank and valve system is integrated in the system.

Different sensors can be attached to the patients for measuring the various examination possibilities. The sensors and pneumatic system are fully integrated and controlled by hardware and software in connection with a PC Windows-based computer.

A number of special developed software programs for various diagnostic tests support the system.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

peripheral vascular

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Prescription device by a physician

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Osborn Medical Corporation undertook extensive verifications of the software and testing to appropriate standards to verify the Phlebotest's safety and functional outcomes.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K882547

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 870.2780 Hydraulic, pneumatic, or photoelectric plethysmographs.

(a)
Identification. A hydraulic, pneumatic, or photoelectric plethysmograph is a device used to estimate blood flow in a region of the body using hydraulic, pneumatic, or photoelectric measurement techniques.(b)
Classification. Class II (performance standards).

0

4 2002 NOV

Image /page/0/Picture/1 description: The image shows the logo for Osborn Medical. The logo consists of a stylized human figure with arms raised above its head, followed by the text "Osborn Medical" in a serif font. The figure is black, and the text is also black.

osbornmed@osbornmedical.com

Customer Service: 800.535.5865 Fax: 507.932.5044 Telephone: 507.932.5028

100 West Main P.O. Box 324 Utica, MN 55979 USA

022047

510(k) SUMMARY of SAFETY and EFFECTIVENESS

A. General Information

    1. Submitter's Name: Osborn Medical Corporation
  • 100 West Main 2. Address: Utica Minnesota 55979
    1. Telephone: 507-932-5028
    1. Contact Person: Bill Davis
    1. Date Prepared: June 18, 2002
    1. Registration Number: 2184046

B. Device

  • Phlebotest 2000 1. Name:
    1. Trade Name: Phlebotest 2000
    1. Common Name: Plethysmograph
  • Plethysmograph 4. Classification Name:
    1. Product Code: JOM
    1. Class: II
    1. Regulation Number: 870.2870

C. Identification of Legally Marketed Devices

  • l. Name: Varitest (Phlebotest) 2. K Number: K882547
    w . o s b o r n m e d i c a l . e o ۱۱: | | |

1

K022047 22/2

D. Description of the Device

The PHLEBOTEST 2000 is a system designed for peripheral vascular diagnostic investigations.

The center of the system is a specially developed patient chair, which can be positioned according to the investigation performed. The patient can be in a sitting or laying position, with legs positioned in different angels using the movable heel and foot support. Patient elevation between laying and sitting positions can be carried out in various speeds according to investigational requirements.

All movements are carried out with low-voltage electrical motors and are directed by a remote hand controller. A pneumatic system consisting of a compressor, pressure tank and valve system is integrated in the system.

Different sensors can be attached to the patients for measuring the various examination possibilities. The sensors and pneumatic system are fully integrated and controlled by hardware and software in connection with a PC Windows-based computer.

A number of special developed software programs for various diagnostic tests support the system.

E. Intended Use Statement

  • 트 Phlebotest 2000 is a system for peripheral vascular diagnostic investigations.
    • 트 Outflow phethysmography (OP)
    • 트 Passive Drain and Refill (PDR)
    • Exercise Venous Plethysmography (EVP)
    • I Triple Test (TTT) Combination of OP, PDR, and EVP
    • 프 Either Strain Gauges or Air Pressure Cuffs

F. Technical Characteristics Summary

The Phlebotest 2000 is substantially equivalent to the Eureka Varitest (Phlebotest) cleared on November 3, 1988.

Osborn Medical Corporation undertook extensive verifications of the software and testing to appropriate standards to verify the Phlebotest's safety and functional outcomes.

2

Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes coiled around it. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the caduceus symbol. The logo is black and white and appears to be a scan of a document.

: 发生

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

NOV. 4 2002

Osborn Medical, Inc. c/o Mr. Bill D. Davis President 100 West Main P.O. Box 324 Utica, Minnesota 55979

Re: K022047

Trade Name: Phlebotest 2000 Regulation Number: 21 CFR 870.2780 Regulation Name: Hydraulic, Pneumatic, or Photoelectric Plethysmograph Regulatory Class: Class II (two) Product Code: JOM Dated: October 8, 2002 Received: October 9, 2002

Dear Mr. Davis:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

3

Page 2 - Mr. Bill D. Davis

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely vours.

Bram D. Zuckerman, M.D.
Director

Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

510(k) Number: To be determined 长心 乙

Device Name: Phlebotest 2000

Indications for Use:

  • Phlebotest 2000 is a system for peripheral vascular diagnostic investigations. ●
    • Outflow phethysmography (OP) .
    • Passive Drain and Refill (PDR) ●
    • Exercise Venous Plethysmography (EVP) .
    • Triple Test (TTT) Combination of OP, PDR, and EVP ●
    • Either Strain Gauges or Air Pressure Cuffs .
    • Prescription device by a physician

PLEASE DO NOT WRITE BELOW THIS LINE -Continue on another Page if needed

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use X

OR

OVER-THE-COUNTER USE (optional Form 1-2-96)

Division of Cardiovascular & Respiratory Devices
510(k) Number K022047